Wyeth's Recognition of the Worth of Biotech
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 68 (Table of Contents)
Published: 1 Feb-2006
DOI: 10.3833/pdr.v2006.i68.557 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
In the space of just 2 weeks, at the close of 2005 and creeping into 2006, top 20 pharma company Wyeth signed three high-value product deals, potentially totalling over US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018